Antihypertensive Treatment in Postmenopausal Women: Results from a Prospective, Randomized, Double-Blind, Controlled Study Comparing an ACE Inhibitor (Moexipril) with a Diuretic (Hydrochlorothiazide)

Publisher： Karger

E-ISSN： 1421-9751|89|4|271-276

ISSN： 0008-6312

Source： Cardiology, Vol.89, Iss.4, 2008-10, pp. : 271-276

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

NBI‐98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double‐blind, placebo‐controlled study

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 12, 2015-10 ,pp. : 1681-1687

John Wiley & Sons Inc

Access to resources Recommend Favorite

Promoting Mindfulness in Psychotherapists in Training Influences the Treatment Results of Their Patients: A Randomized, Double-Blind, Controlled Study

By  

Psychotherapy and Psychosomatics, Vol. 76, Iss. 6, 2007-10 ,pp. : 332-338

Karger

Access to resources Recommend Favorite

Transurethral intraprostatic injection of botulinum neurotoxin type A for the treatment of chronic prostatitis/chronic pelvic pain syndrome: results of a prospective pilot double‐blind and randomized placebo‐controlled study

By  

BJU INTERNATIONAL, Vol. 116, Iss. 4, 2015-10 ,pp. : 641-649

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of a combined alendronate and calcitriol agent (Maxmarvil®) on bone metabolism in Korean postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study

By Rhee Y.   Kang M.   Min Y.   Byun D.   Chung Y.   Ahn C.   Baek K.   Mok J.   Kim* D.   Kim** D.   Kim H.   Kim Y.   Myoung S.   Kim*** D.   Lim S.-K.  

Osteoporosis International, Vol. 17, Iss. 12, 2006-12 ,pp. : 1801-1807

Springer Publishing Company

Access to resources Recommend Favorite

Effects of Fostamatinib, an Oral Spleen Tyrosine Kinase Inhibitor, in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate: Results From a Phase III, Multicenter, Randomized, Double‐Blind, Placebo‐Controlled, Parallel‐Group Study

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 66, Iss. 12, 2014-12 ,pp. : 3255-3264

John Wiley & Sons Inc

Access to resources Recommend Favorite